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Restrictions in neuronal fate occur during the transi- 
tion from a multipotential to a postmitotic cell. This 
and later steps in neuronal differentiation are deter- 
mined by extracellular signals. We report that basic 
fibroblast growth factor is mitogenic for stem cells and 
is a differentiation factor for calbindin-expressing hip- 
pocampal neurons. The neurotrophin NT-3 is a differ- 
entiation factor for the same neurons but does not af- 
fect proliferation. NT-3 and brain-derived neurotrophic 
factor promote the maturation of neurons derived from 
stem cells that have been grown in vitro. These results 
define functions for basic fibroblast growth factor and 
neurotrophins in the differentiation processes that di- 
rect a multipotential stem cell to a specific neuronal fate. 
Introduction 
During the development of the nervous system, precur- 
sors give rise to different types of neuronal and glial cells 
on a precise schedule (McKay, 1989; Anderson, 1993; 
Barres and Raff, 1994). Fate mapping experiments show 
that many neurons and glia in the CNS are derived from 
multipotential cells (Turner and Cepko, 1987; Gray et al., 
1988; Wetts and Fraser, 1988). The multipotent nature of 
the precursor cells stresses the role of extracellular signals 
in regulating the switch from stem cell to differentiated 
product. Transplantation experiments in the cerebral cor- 
tex show that these signals act at the time a dividing cell 
differentiates to a postmitotic neuron (McConnell and Kaz- 
nowski, 1991). These results emphasize the need to define 
Iigand-receptor systems that regulate early steps in neu- 
ronal differentiation. 
Conditions that allow the proliferation and differentiation 
of neural precursors are necessary for the analysis of 
mechanisms and factors regulating cell differentiation and 
fate choice. In culture, precursor cells derived from the 
mammalian CNS can proliferate and, under some condi- 
tions, differentiate into neurons and glia (Raff et al., 1983; 
Temple, 1989; Cattaneo and McKay, 1990; Reynolds et 
al., 1992; Davis and Temple, 1994). Oligodendrocyte pre- 
cursors derived from the rat optic nerve require acombina- 
tion of signals to differentiate into postmitotic cells (for a 
review, see Barres and Raff, 1994). In the sympatho- 
adrenal lineage, the continued action of different signals 
may synergistically promote neuronal differentiation, nerve 
growth factor (NGF) dependence for survival, and matura- 
tion of sympathetic neurons (for a review, see Anderson, 
1993; Ip et al., 1994). The differentiation of neuronal cells 
in the CNS is not so well understood. The experiments 
reported here define the functions of soluble factors that 
regulate different steps in the transition from a precursor 
to a neuron in the hippocampus. 
High levels of basic fibroblast growth factor (bFGF) and 
its receptors are found during mitotically active phases of 
chicken and rat nervous system development (Gonzalez, 
et al., 1990; Wanaka et al., 1991; Peters et al., 1992). The 
expression of neurotrophin3 (NT-3), brain-derived neuro- 
trophic factor (BDNF; Maisonpierre et al., 1990; Ernfors 
et al., 1992) and tyrosine receptor kinase (Trk) receptors 
(Klein et al., 1990; Tessarollo et al., 1993) in the hippocam- 
pal formation suggests that these neurotrophins act on 
postmitotic neurons ratherthan in proliferativecells. bFGF 
stimulates the proliferation and survival of hippocampal 
cells (Walicke et al., 1986; Collazo et al., 1992; Ohsawa 
et al., 1993; Ray et al., 1993). NT-3 is a neurotrophic factor 
for calbindin-positive hippocampal neurons (Collazo et al., 
1992; Ip et al., 1993). Though these reports show that 
bFGF and NT-3 are neurotrophic for hippocampal neu- 
rons, they do not distinguish among differentiation, matu- 
ration, and survival mechanisms of action. In this paper, 
we investigate more precisely the cellular targets and func- 
tions of neurotrophins and bFGF in the development of 
hippocampal neurons. 
Hippocampal ceils were grown under two conditions: 
acutely dissociated from rat embryonic day 16 (E16) em- 
bryos and after in vitro passaging of the cells in the pres- 
ence of bFGF. Cells were analyzed for the expression of 
stem cell, neuronal, and glial markers at different days in 
culture. The ability of acutely dissociated and expanded 
precursor cells to differentiate in response to bFGF and 
neurotrophins was assessed. Our  results show that both 
bFGF and NT-3 are differentiation factors for calbindin- 
expressing hippocampal neurons. bFGF is also a mitogen, 
stimulating the proliferation of a cell that expresses nestin, 
a marker of neuroepithelial stem cells (Hockfield and 
McKay, 1985; Frederiksen and McKay, 1988; Cattaneo 
and McKay, 1990; Lendahl et al., 1990; Zimmerman et 
al., 1994). Nestin-positive cells that have been expanded 
in vitro can differentiate to express neuronal antigens and 
morphologies in response to neurotrophins. These results 
suggest that bFGF, NT-3, and BDNF interact to promote 
the differentiation of hippocampal neurons from their pro- 
liferating stem cells. 
Results 
Effects of bFGF and NT-3 on Hippocampal Cells 
Effect of bFGF on Cell Number and Type 
The effect of increasing concentrations of bFGF on the 
labeling index (bromodeoxyuridine [BrdU] incorporation) 
was tested in short-term cultures before the cells were 
passaged and in cells that were passaged twice. Figure 
1 a shows that in both cases, increasing concentrations of 
bFGF from 0 to 5 nglml produced a 2- to 3-fold increase 
Figure 1. Characterization of the Effects of bFGF on Hippocampal 
Primary Cells 
(a) Dose-response curve of the bFGF effect on the BrdU incorporation 
of primary hippocampal cells in culture. Cells were prepared from rat 
embryonic hippocampus on El6 and plated onto polyornithine-coated 
well chambers at 45,000 cellsIcm2. Cells were grown in N2 medium 
and varying concentrations of bFGF during 5 days without passage 
(passage 0; circles). For passage 2 conditions (triangles), cells were 
passaged twice in 11 days in bFGF at 5 nglmi and then incubated 
with varying concentrations of bFGF for another 5 days. bFGF was 
replaced every 2-3 days. BrdU was added to the cultures at a final 
concentration of 10 f.rM for 16 hr prior to fixation. Cells were rmmuno- 
stained with antt-BrdU antibody. 
(b-e) Identification of hippocampal cells growing in bFGF. Cells were 
grown in N2 medium in the presence of 5 rig/ml bFGF or BSA. At 
different days in vitro (DIV), cells were fixed and immunostained for 
BrdU (b), nestin (c), GFAP (d), MAP2 (e), or calbindin (f). In all panels, 
a total of 10 fields were counted under a phase-contrast microscope 
using 400 x magnification. Results are expressed as percentage of 
cells expressing a specific marker per 10 fields or, in inset of (e), as 
the number of cells expressing MAPP. 
For each condition, 4-5 samples were tested, and the data are the 
average + SEM of 2 experiments. During the entire period of study, 
80%-90% of the cells maintained in bFGF expressed nestin (c), an 
intermediate protein characteristic of neuroepithelial cells. Single as- 
terisk, p < .05; two asterisks, p < .Ol ; three asterisks, p < ,001 (statisti- 
cal significanceof bFGFdataversus BSAcontrols). Single pound sign, 
p< .05; two pound signs, p< .Ol; three pound signs, p < ,001 (statistical 
significance of each value versus previous value). Shills indicate bro- 
ken scale. 
in the percentage of BrdU-positive cells in the cultures. 
Much higher concentrations of bFGF (100 rig/ml) showed 
no significant increase in the percentage of BrdU-positive 
cells. Therefore, a saturating dose of 5 nglml bFGF was 
used throughout this study. 
To test whether the effect of bFGF on the proliferative 
capacity of these ceils changed with time, the labeling 
Table 1. Antigen Expression and BrdU Labeling by Acutely 
Dissociated Hippocampal Cells Growing in bFGF 
---___ 
Percentage of 




Cells were prepared from rat embryonic hippocampus on El6 and 
plated onto polyornithrne chambers at 45,000 cells/cm2. Cells were 
grown in N2 medium in the presence of 5 nglml bFGF for 3 days and 
exposed to 10 PM BrdU during 18 hr prior to fixation. Cells were fixed 
and double-stained with anti-nestin, anti-BrdU, or anti-calbindin anti- 
bodies and visualized by using rhodamine- and fluorescein-conjugated 
secondaryantibodies.AtotaloflOfieldswerecountingunderafluores- 
cence microscope using 200 x magnification. The values are percent- 
age of nestin cells that are BrdU positive or percentage of calbindin 
cells that are nestin positive or BrdU negative. 
index was measured in the presence and absence bFGF 
cells at various times in culture. Figure 1 b shows that after 
2 days in vitro (DIV), the proportion of BrdU-positive cells 
was similar (about 50%) in cells grown with and without 
bFGF. In the first week in culture, the percentage of cells 
that incorporated BrdU in the presence of bFGF increased 
from 50% to 90%. After 2 weeks in culture, there was a 
decrease in the proliferative capacity of the bFGF-ex- 
panded cells, declining to a labeling index of 30% at the 
last timepoint examined (27 days). In the absence of added 
bFGF, there is a rapid decrease in labeling index, and cells 
die. These results are consistent with a a simple model in 
which high affinity receptors for bFGF are directly respon- 
sible for proliferation. 
To determine the phenotype of the cells that proliferate 
and survive in the presence of bFGF, a panel of antibodies 
was used. Antibody against nestin, an intermediate fila- 
ment protein, was used to recognize neural precursor cells 
(Hockfield and McKay, 1985; Frederiksen and McKay, 
1988; Lendahl et al., 1990; Tohyama et al., 1992; Zimmer- 
man et al., 1994). Neurons were identified by the expres- 
sion of microtubule-associated protein 2 (MAP2; Matus 
et al., 1986). In the hippocampus, many dentate granule 
neurons and some pyramidal cells and interneurons 
express the calcium-binding protein calbindin (Sloviter, 
1989). Therefore, an antibody against this protein was 
used to detect this neuronal subtype. Antibody against 
glial-fibrillary acidic protein (GFAP) was used as a general 
marker for astrocytes (Bignami et al., 1972). 
Figure lc shows that in the presence of bFGF, there is 
a persistent expression of nestin, ranging from 80%-90% 
of the cells during the entire time course examined. In 
cultures examined 3 days after plating, more than 90% 
of the nestin-positive cells were also BrdU positive (Table 
1). After 6 DIV, most of the nestin-expressing cells growing 
in bFGF showed small pyramidal morphology bearing 
short processes (unpublished data). Nestin expression de- 
creased in the bovine serum albumin controls, and after 
6 days, only about 15% of the cells were nestin positive 
(Figure lc). The correlation between nestin expression 
and proliferation suggests that cells growing in the ab- 
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sence of bFGF down-regulate nestin and stop prolifer- 
ating. 
The fraction of cells expressing GFAP increased during 
prolongedexposureof hippocampalculturesto bFGF(Fig- 
ure Id). Initial GFAP expression in these cultures is low 
(1 O/o). The percentageof GFAP-expressing cells increased 
in cultures treated with bFGF compared with controls, 
reaching 25% after 27 DIV. In this culture system, GFAP- 
positivelnestin-positive cells, as well as GFAP-positive/ 
nestin-negative cells, were present (data not shown). 
These results show that bFGF promotes the proliferation 
of neuroepithelial cells that give rise to astrocytes. 
In the presence of bFGF, there was a significant de- 
crease over time in the percentage of cells expressing the 
neuronal antigen MAP2 (Figure 1 e). After the second week 
in culture, about 5% of the cells were MAP2 positive. This 
observation was reproduced using other neuronal anti- 
gens, such as neuron-specific enolase and neurofilament 
(data not shown). During the first 6 DIV, the decrease in 
the proportion of MAP2-positive cells can be explained by 
the increase of cells expressing nestin (Figure 1 c). When 
hippocampal cells were grown in the presence of bFGF 
for 2 weeks without passaging, approximately 85% of the 
cells were MAP2 negative (data not shown). This result 
indicates that the increase in nestin-positive cells is not a 
consequence of passaging the cultures. 
In the control cultures, the proportion of cells expressing 
MAP2 increased over time, reaching 50% at 6 days in 
culture. There is a reciprocal loss of nestin-positive cells. 
These data show that neurons differentiate when dissoci- 
ated cells are placed in culture. bFGF does not influence 
this process, as there is little effect on the number of MAP2- 
positive cells. At 11 days, most of the cells die in the ab- 
sence of bFGF (Figure le, inset). These results show that 
bFGF does not increase the total number of neurons, but 
it is a survival factor for hippocampal neurons, as has pre- 
viously been reported (Walicke et al., 1986) and can be 
seen at 11 DIV in Figure le (inset). 
In contrast, bFGF has specific neurotrophic effects on 
a subset of hippocampal cells, the calbindin-expressing 
neurons(Collazo et al., 1992; Ipet al., 1993). A time course 
of the effectsof bFGFon calbindin-positive neurons shows 
that the fraction of cells expressing calbindin was 2.5- to 
8-fold greater in the bFGF cultures than in the controls 
(Figure If). During the first week, 150/o-20% of the cells 
were calbindin positive. bFGF increases the number of 
calbindin-expressing cells by 2 days in culture. However,  
the effect of bFGF on MAP2-positive cells was first visible 
after a week in culture (Figure le, inset). Experiments de- 
scribed below extend these observations and show that 
bFGF acts as a differentiation factor on calbindin-positive 
neurons. 
Effect of bFGF and NT-3 on Calbindin Expression 
by Hippocampal Neurons 
The trophic effects of bFGF and NT-3 on hippocampal 
calbindin-expressing neurons raise three further ques- 
tions. First, are these neurotrophic effects a consequence 
of a differentiation pathway triggered by the growth factor 
or a survival effect on a differentiation program that is 
initiated by other signals? Second, do NT-3 and bFGF act 
on the same population of responding cells? Third, if the 
same cells respond to the factors, do independent recep- 
tor systems mediate the neurotrophic effects of bFGF and 
NT-3? 
The short-term effects of bFGF on calbindin-positive 
cells over the first 6 DIV (Figure If) could be explained by 
Figure 2. Induction of Calbindin Cell Differentiation Promoted by 
bFGF and NT-3 
(a) rapid induction of calbindin expression by bFGF and NT-3 in short- 
term cultures. Addition of growth factors produced a 5. to 7-fold in- 
crease in the number of calbindin-expressing cells during the first 2 
days. 
(b) The induction of calbindin by bFGF was saturated at concentrations 
equal to or greater than 5 nglml. 
(c and d) During the first 2 DIV, no differences among bFGF, NT-3, 
or controls on [3H]thymidine incorporation by the cells(c) or in the total 
number of ceils (d) were observed. 
(e) The percentage of calbindin-positive cells at the time when maximal 
levels were found, 2 days. bFGF plus NT-3 produced the same in- 
crease in calbmdin-positive cells as either factor added alone. 
(f) Selective blocking of calbindin induction by specific antibodies 
against bFGF or NT3 
Hippocampal cells were prepared and plated as described in Figure 
1. Cells were grown in N2 medium in the presence of varying concen- 
trations of bFGF, 20 nglml NT-3, 5 nglml bFGF + 20 nglml NT-3, or 
BSAforthe indicated numberof days. Anti-bFGF (I:1 0O)and anti-NT-3 
(1:iOO) antibodies were added to the cells at the time of plating and 
replaced every day for 2 days. [3H]thymidine was added to the cells 
at a final activity of 2 uCi/ml. At different DIV, cells were fixed and 
immunostained for calbindin-Dz.Ko.. A total of 10 fields were counted 
under a phase-contrast microscope using 200 x magnification. Re- 
sults are expressed as number or percentage of cells expressing cal- 
bindin, as the total number of cells per 10 fields, or as mcorporated 
counts per minute. For each condition, 4-5 samples were tested, and 




either a survival or differentiation action. The effect of 
bFGF and NT-3 on calbindin expression at short times in 
culture was measured to establish whether these factors 
act as differentiation agents. As shown in Figure 2a, both 
bFGF and NT-3 rapidly increased the number of calbindin- 
expressing cells (7-fold and 5-fold, respectively), reaching 
maximum levels after 2 days in culture. In bovine serum 
albumin (BSA) controls, there was a 3-fold increase during 
the same period of time. 
There is strong evidence that the differentiation and pro- 
liferative functions of bFGF are independent. The dose- 
response curves for the proliferative and differentiation 
effects of bFGF are similar (Figure la and Figure 2b), sug- 
gesting that both functions are directly mediated by high 
affinity receptors. When El 6 hippocampal cells are ana- 
lyzed immediately after dissection, more than 80% of the 
cells are nestin positive. Though this level of nestin expres- 
sion is maintained by bFGF, only 25% of the calbindin- 
positive cells express nestin after 3 days in culture (Table 
l), suggesting that there are two populations of cells that 
respond to bFGF, either by proliferating or by differenti- 
ating. 
This conclusion is supported by additional data. Over  
90% of the calbindin-positive cells are not proliferating in 
these short-term cultures, as measured by BrdU incorpo- 
ration (Table 1). During the first 2 days in culture, bFGF 
and NT-3 have no effect on the thymidine incorporation, 
nor do they influence the number of cells (Figures 2c and 
2d). These data are consistent with a model in which tyro- 
sine kinase receptors for bFGF and NT-3 can stimulate 
calbindin expression in the early stages of neuronal differ- 
entiation. 
When bFGF and NT-3 were added together to cultured 
cells, the response was not additive (Figure 2e). The lack 
of an additive effect shows that the same population of 
cells responds to bFGF and NT-3. To test whether bFGF 
and NT-3 induced calbindin expression by independent 
pathways, we used specific antibodies that block the func- 
tion of NT-3 and bFGF. Blocking antibodies against NT-3 
or bFGF inhibited the increase in the number of calbindin- 
expressingcellswithout affecting theresponseto theother 
growth factor (Figure 29. Antibodies did not have signifi- 
cant effect on the total number of cells (data not shown). 
These results suggest that the NT-3 and bFGF effects are 
mediated by independent receptors on the same cells. 
These results show that NT-3 and bFGF cause an in- 
crease in the number of calbindin-positive cells within 
hours after plating, and this effect is maintained for several 
days (Figure 2a). The longer term effects of these extracel- 
lular signals show that there is a survival effect on calbin- 
din-positive neurons. Double-labeling studies show that 
calbindin-positive neurons up-regulate c-Fos in response 
to NT-3 (Collazo et al., 1992), suggesting that the survival 
effect is directly mediated by Trk receptors on the neurons. 
Similar studies are necessary to determine whether the 
survival effects of bFGF are mediated by receptors on the 
neurons or indirectly through another cell. 
Differentiation of Cells Expanded in bFGF 
The results above show that bFGF and NT3 are differentia- 
tion factors in acutely dissociated hippocampal cultures, 
Figure 3. BDNF and NT-3 Increase the Expression of Neuronal Mark- 
ers on Hippocampal Cells Expanded in bFGF 
Hippocampal cells were prepared and plated as described in Figure 
1. Cells were passaged twice in 13 days in N2 medium in the presence 
of 5 nglml bFGF. Then, bFGF was removed, and cells were washed 
and incubated for an additional 5 days in the presence of 20 nglml 
BDNF, 20 nglml NT-3, or 20 nglml NT-4/5. As controls, some cells 
were maintained in bFGF or switched lo BSA for 5 days. In (d), concen- 
trations of BDNF of 1 nglml and 100 nglml were also tested after the 
third passage of the ceils. Growth factors were replaced every 2 days. 
Cells were fixed and immunostained for nestin (a), GFAP (b), MAP2 
(c and d), calbindin-D*,,. (e), or synapsin I(9. A total of 10 fields were 
counted under a phase-contrast microscope using 200x magnifica- 
tion (nestin, GFAP, MAP2) or 100 x magnification (calbindin and sy 
napsin I). Lower magnification in the counting of calbindin-positive or 
synapsin I-positive cells was chosen to increase the level of confi- 
dence. In the presence of BDNF. the MAPP-positive cells and calbin- 
din-positive cells represent 12% and 5%, respectively, of total cells. 
Results are expressed as the number of cells expressing a specific 
marker per 10 fields. For each condition, 4-5 samples were tested, 
and the data are the average f SEM of 2 experiments. Single asterisk, 
p < .05; two asterisks, p < .Ol; three asterisks, p < ,001 (statistical 
significance of each data versus BSA values). 
and that the same cells can respond to either factor by 
expressing calbindin. These results contrast with the pro- 
liferative effects of bFGF, as most of the cells growing in 
bFGF remained as neural precursor cells according to the 
expression of nestin and lack of expression of neuronal 
antigens. The simplest interpretation of this data is that 
acutely dissociated hippocampal cultures contain two 
bFGF-responsive cells: a cell that proliferates and a cell 
that differentiates. The differentiation functions of NT-3 on 
acutely dissociated cells, along with the neurotrophic roles 
of NT-3, BDNF, and NT-4/5 on neuronal cells (Alderson 
et al., 1990; Collazo et al., 1992; Segal et al., 1992; Ip et 
yr$feration and Differentiation of Stem Cells 
Figure 4. SDNF Increases the Number of Synapsin I-Positive Neu- 
rons on the bFGF-Expanded Cells 
Hippocampal cells were prepared and plated as described in Figure 
3. Cells were fixed and immunostained for MAP2 and synapsin I. 
(a) MAPZ-positive cells visualized using fluorescein-conjugated sec- 
ondary antibody present complex morphologies, having pyramidal ceil 
bodies and bearing long processes, 
(b) Synapsin I accumulates in puncta in close contact with processes 
as visualized using rhodamine-conjugated secondary antibody. 
(c) Double exposure for the MAP2 and synapsin I staining reveals 
that most of the synapsin-rich puncta do not show MAP2 staining 
as indicated by the orange-red color (arrows) instead of the yellow 
(arrowhead). 
Bar, 10 urn. 
al., 1993; Ghosh et al., 1994) prompted us to test their 
effects on the bFGF-expanded cells. 
Cells growing in bFGF for 13-18 days (passages 2 and 
3) were switched to BDNF, NT-3, NT-415 (20 rig/ml), BSA, 
or maintained in bFGF for another 5 days. The removal 
of the mitogen produced a major decrease in the number 
of nestin-positive cells (Figure 3a). The number of cells 
expressing the astrocytic marker GFAP was also reduced 
by 30%-40% in neurotrophin conditions and approxi- 
mately 55% in BSA (Figure 3b). These results show that 
removal of the mitogen reduces the number of cells ex- 
pressing nestin or GFAP and that neurotrophins have little 
effect in these assays. 
Because the loss of nestin expression in vivo and in 
vitro correlates with the transition of neuronal stem cells 
to neurons (Frederiksen et al., 1988; Frederiksen and 
McKay, 1988; Cattaneo and McKay, 1990; Hayes et al., 
1991) it is interesting to ask whether the in vitro expanded 
nestin-positive cells can also acquire neuronal properties. 
Cells were analyzed for expression of MAP2, calbindin, 
and synapsin proteins and for morphological changes in 
response to bFGF withdrawal and neurotrophin addition. 
Simply withdrawing bFGF has little effect on the number 
of MAPBpositive cells (Figures 3c and 3d), and calbindin- 
expressing cells (Figure 3e). In contrast, expression of 
MAP2 was enhanced by 2-fold in the presence of BDNF 
or NT-3, reaching saturation at 20 nglml of neurotrophic 
factor (Figure 3d). BDNF, NT-3, and NT-4/5 also increased 
the number of calbindin-positive cells by 3-fold, 2-fold, and 
2.5-fold, respectively, compared with BSA (Figure 3e). In 
the presence of BDNF, 12% of the cells expressed neu- 
ronal markers. 
Changes in the expression of synaptic proteins and neu- 
ronal morphology during development have been related 
to different stages of neuronal maturation (Dotti et al., 
1988; Fletcher et al., 1991; Verdi et al., 1994). Removal 
of bFGF and addition of BDNF leads to a 70% increase 
in the number of cells expressing synapsin I compared 
with BSA (Figure 3f). Synapsin is mostly concentrated in 
puncta, often associated with MAP2-positive processes, 
but is not colocalized with that protein (Figure 4). Note 
that the effect of BDNF is more pronounced than the effect 
of NT-3 in this assay. Neurotrophin-treated cells showed 
a significantly larger cell body area, a greater number of 
processes and branches, and longer processes compared 
with cells switched to BSA or maintained in bFGF, as 
shown in Table 2 and Figure 5. These results show that 
cells expanded in bFGF express antigens and morpholo- 
gies characteristic of differentiating hippocampal neurons 
in response to NT-3 and BDNF. 
Discussion 
Experiments with single cell cultures of primary cells and 
clonal cell lines show differentiation to both neuronal and 
glial fates in vitro and in vivo (Temple, 1989; Frederiksen 
et al., 1988; Renfranz et al., 1991; Snyder et al., 1992; 
Davis and Temple, 1994). These experiments emphasize 
the multipotential nature of neuroepithelial cells in the 
CNS. They raise interesting questions about the signals 
that regulate the transition from proliferating cell to a post- 
mitotic, differentiated product. The experiments reported 
here analyze the proliferation and differentiation of hippo- 
campal cells under two conditions: acutely dissociated 
from El6 embryos and after in vitro expansion in the pres- 
ence of bFGF. Growth factors that act on these cells as 
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Cell Body Area (cm’) 
74.3 * 3.7 (110) 
67.3 2 4.0 (100) 
91.3 * 3.4 (136)b 
95.9 f 4.3 (142)b 
Number of Processes 
and Branches 
6.2 * 0.5 (117) 
5.3 _’ 0.5 (100) 
6.4 f 0.4 (159)b 
9.0 -t 0.5 (170)” 
Length of Longest 
Process (pm) 
96.4 f 13.3 (144) 
66.0 + 6.4 (100) 
136.3 f 13.2 (203) 
124.7 f 11.1 (163)b 
El 6 hippocampal cells were grown and immunostained for calbindin-D 28kDs, as described in Figure 3. Cells were examined on an inverted microscope 
set up for differential interference contrast optics with a 40x objective using bright-field optics. The images were collected with a videocamera 
and processed to enhance contrast using a computer-based system. The cell body area, number of processes and branches, and length of longest 
process of 30 cells for each condition were measured. Results are expressed as average * SEM. Given in parentheses is the percentage for 
each value versus BSA conditions (100%). 
B p < .Ol. 
b p < ,001 (statistical significances versus BSA values). 
mitogens and differentiation agents are defined. bFGF 
causes the proliferation of neuroepithelial cells expressing 
the intermediate filament nestin. bFGF and NT-3 induce 
neuronal differentiation by acting on early postmitotic 
cells. NT-3 and, more effectively, BDNF promote matura- 
tion of cells that have been expanded in vitro to express 
neuronal morphologies and synaptic antigens. These ex- 
periments identify functions for extracellular signals in the 
mechanisms that control differentiation of a specific sub- 
set of hippocampal neurons from proliferating precursors. 
bFGF Stimulates Proliferation of 
Nestin-Positive Cells 
bFGF has been shown to have trophic and proliferative 
effects on hippocampal primary cells, although its cellular 
targets have not been precisely defined (Walicke et al., 
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Figure 5. Calbindin-Expressing Cells Growing in the Presence of bFGF Show a More Mature Morphology when Switched to Neurotrophins 
In the absence of bFGF, the addition of BDNF (a) or NT-3 (b) to the cultures promoted the acquisition of a more elaborate neuronal morphology 
by the calbindin-expressing cells as compared with cells maintained in bFGF (c) or switched to BSA (d). See Table 2 for measurements of the 
cell body area, number of processes and branches, and length of the longest process. Arrows indicate long processes for which the antibody 
staining was weak. Hippocampal cells were prepared and plated as descrtbed in Figure 3. Cells were fixed and immunostained for calbindin-Dnaroa 
and visualrzed by using avidin-biotin-horseradish peroxidase complex and DAB under bright-field optics using 200x magnification. Bar, 25 Wm. 
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1986; Collazo et al., 1992; Ohsawa et al., 1993; Ray et 
al., 1993). bFGF exerted a strong proliferative effect on 
hippocampal cells, so that after a month in culture, 30% of 
the cells incorporated BrdU (see Figure 1 b). Even though 
bFGF was able to maintain cell proliferation, there was a 
progressive decrease in the labeling index after the first 
2 weeks in vitro, which was not prevented by addition of 
high concentrations of the growth factor, such as 100 ngl 
ml (see Figure 1 a). Astrocytic differentiation occurring in 
the culture may alter the proliferative responses to bFGF 
(Gao et al., 1991). 
One of the more striking features of the cells growing 
in bFGF is the large proportion of dividing cells expressing 
nestin (see Figures 1 b and 1 c; Table 1). These data and 
the decrease in the fraction of cells expressing neuronal 
markers (see Figure le) suggest that the hippocampal cell 
population that proliferates in response to bFGF is mainly 
composed of neuroepithelial stem cells. These and previ- 
ous in vitro results (Deloulme et al., 1991; Ohsawa et al., 
1993; Ray and Gage, 1994) along with the abundant ex- 
pression of bFGF (Gonzalez et al., 1990) and bFGF recep- 
tors (Wanaka et al., 1991; Peters et al., 1992) during 
phases of active cell proliferation in the CNS, suggest a 
developmental role for bFGF in stimulating the prolifera- 
tion of neuroepithelial cells giving rise to neuronal and glial 
cells. 
Consistent with this and in agreement with previous re- 
ports (Perraud et al., 1988; Ray and Gage, 1994) our re- 
sults suggest that bFGF maybe a mitogen and/or differen- 
tiation factor for astrocyte precursors (see Figure Id). The 
survival of GFAP-positive cells requires the continued 
presence of FGF, since withdrawal of the growth factor 
from the cultures was followed by astrocytic death (see 
Figure 3b). After 2 weeks in vitro, GFAP-positive cells can 
be distinguished by the presence or absence of nestin 
expression, suggesting that these cells represent two dif- 
ferent stages in astrocytic differentiation. 
bFGF and NT-3 induce Calbindin 
Neuronal Differentiation 
bFGF and NT-3 are survival factors for hippocampal cal- 
bindin-expressing neurons in vitro (Collazo et al., 1992; 
Ip et al., 1993). We have previously shown using a Fos- 
induction assay that calbindin-positive neurons respond 
directly to NT-3 (Collazo et al., 1992). The data reported 
here extend our understanding of the cellular targets for 
both bFGF and NT-3. After 3 days in culture, the cells 
that express calbindin are not proliferating, and nestin is 
down-regulated in the calbindin-expressing cell popula- 
tion (Table 1). The rapid induction of calbindin expression 
by bFGF and NT-3 (see Figure 2a) contrasts with the lack 
of effect on total cell number (see Figure 2d). These results 
show that bFGF and NT-3 act at early stages of neuronal 
differentiation and induce signaling pathways that specify 
a particular neuronal subtype. As suggested by the lack 
of additive effect (see Figure 2e), bFGF and NT-3 induce 
calbindin differentiation acting on the same cell popula- 
tion. Our results with blocking antibodies suggest that 
bFGF and NT-3 promote calbindin expression indepen- 
dently. 
It is remarkable that in these hippocampal cultures, 
bFGF acts both as a mitogen and as a differentiation fac- 
tor. It is likely acting on different cell populations, inducing 
proliferation in the nestin-expressing neuroepithelial cells 
and differentiation in the precursors for calbindin-positive 
neurons. The dose-response curves for BrdU incorpora- 
tion and calbindin induction suggest that bFGF interacts 
with high affinity receptors to trigger diverse actions. It 
is important to establish how this switch in signaling is 
achieved. 
Though there are many studies reporting the neuro- 
trophic effects of neurotrophins (Korsching, 1993) our re- 
sults show that NT-3 is adifferentiation factor for calbindin- 
positive hippocampal neurons. Our data also suggest that 
after 2 days in vitro, both bFGF and NT-3 support the 
survival of calbindin-positive neurons. But it is the earlier 
effects on the differentiation of calbindin-positive neurons 
that are most thoroughly documented in the data pre- 
sented here. The transition from proliferating stem cell to 
postmitotic neuron induces a signaling mechanism that 
links tyrosine kinase receptors to the differentiation of a 
specific neuronal subtype. Receptor number may play an 
important role, as recent studies show that elevated levels 
of EGF and insulin receptors can stimulate neuronal differ- 
entiation in PC12 cells (Dikic et al., 1994; Traverse et al., 
1994). However, the data presented here provide some 
of the first evidence for the specific action of extracellular 
ligands during the transition from multipotential cell to dif- 
ferentiated neuron. 
Mice lacking NT-3, BDNF, TrkC, or TrkB do not show 
gross abnormalities in the CNS (for a review see Klein, 
1994). In the hippocampus, the expression of calbindin is 
decreased only in a small proportion of interneurons in 
mice lacking BDNF (Jones et al., 1994). An explanation 
for these results may be that the absence of one factor 
can be complemented by the presence of another factor. 
We report that bFGF and NT-3 have indistinguishable ef- 
fects on the differentiation of calbindin-positive neurons. 
Neuronal Maturation of Cells Expanded In Vitro 
In vivo, nestin is expressed in mitotic neural precursor 
cells and is lost as postmitotic cells differentiate to neurons 
(Frederiksen and McKay, 1988; Hockfield and McKay, 
1985; Zimmerman et al., 1994). In embryonic rat cortex, 
a parallel decline in the number of nestin-positive cells 
and in CDCP mRNAcoincideswith neuronal differentiation 
(Hayes et al., 1991). In vitro data also show a reciprocal 
down-regulation of nestin expression and the acquisition 
of neuronal antigens and morphology (Cattaneo and 
McKay, 1990). Similarly, neuronal differentiation in acutely 
dissociated cells occurs with a reciprocal decrease in nes- 
tin expression (Table 1; see Figure 2a). Expanded cells in 
bFGF show high levels of nestin and low levels of neuronal 
markers, suggesting that most of the cells remain as pre- 
cursors. A fraction of these cells differentiate to express 
glial markers (see Figure 1 d). It is important to define quan- 
titative assays that measure neuronal maturation in cells 
that have been expanded in vitro. 
In cultures of bFGF-expanded hippocampal cells, with- 
drawal of the mitogen results in a marked decrease in 
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the number of nestin-positive cells (see Figure 3a). The 
addition of BDNF or NT-3 leads to a significant increase 
in the number of cells expressing MAP2 and calbindin (see 
Figures 3c, 3d, and 3e). The increase in the number of 
calbindin-positive neurons was also observed in the pres- 
ence of NT-415 (see Figure 3e). Calbindin-positive cells 
exposed to neurotrophins showed larger cell bodies and 
a greater number of more elaborate processes than cells 
growing in bFGF or switched to BSA (Table 2; see Figure 
5). Morphological changes can be related to different 
stages of neuronal maturation (Dotti et al., 1988; Verdi et 
al., 1994). Our  results show that NT-3, NT-415, and BDNF 
are able to induce neuronal differentiation of the nestin- 
positive cells and/or promote the maturation of calbindin- 
positive cells expanded in bFGF. The pattern of synapsin 
I expression supports this conclusion. The role of neuro- 
trophins promoting the maturation of hippocampal neu- 
rons parallels the reported actions of these factors on de- 
veloping sensory neurons (Wright et al., 1992). 
Sequential roles for neurotrophins in the differentiation, 
survival, and maturation of neuronal cells have been re- 
ported previously (Segal et al., 1992; Buchman and Da- 
vies, 1993; De la Rosa et al., 1994; Ip et al., 1994). Al- 
though BDNF has survival effects on acutely dissociated 
hippocampal calbindin-positive cells, its effect is lower and 
delayed compared with NT-3 (Collazo et al., 1992; Ip et 
al., 1993). Our  results and previously published data (Ip 
et al., 1993) show that calbindin-positive cells are more 
responsive to BDNF with time in culture. This suggests 
that the main role of BDNF on development of these cells 
may not be during early stages of neuronal differentiation 
but at a later stage in neuronal maturation. Consistent with 
this view, BDNF is more effective than NT-3 in increasing 
the number of cells expressing synapsin I (see Figure 3f). 
Synapsin accumulates in puncta, often along and in close 
contact with MAP2 processes (see Figure 4) as has 
been previously described for neurons during maturation 
(Fletcher et al., 1991). The delayed effects of BDNF rela- 
tive to NT-3 in these cultures are consistent with a delay 
in the expression of BDNF and rrkB relative to NT-3 and 
trkC in the hippocampal formation (Ernfors et al., 1992; 
Klein et al., 1990; Maisonpierre et al., 1990; Tessarollo et 
al., 1993). Data from the developing cerebellum also show 
sequential roles for BDNF and NT-3, but in contrast to the 
hippocampus, BDNF acts before NT-3 in the differentia- 
tion of cerebellar granule neurons (Segal et al., 1992). 
The data presented in this work show that cell types, 
stages in cell differentiation, and ligand responses can 
be defined in hippocampal cultures. In combination with 
genetic tools, this experimental system is suitable to char- 
acterize further the many steps that generate the ordered 
structure of the hippocampus from stem cells. 
Experimental Procedures 
Materials 
The materials were purchased from the following sources: calcium 
and magnesium-free Hanks’balanced salt solution (CMF-HESS), Dul- 
becco’s modified Eagle’s Medium (DMEM), DMEM/Nutrient mixture 
F-l 2 (DMEMIFI 2), penicillm-streptomycin, and trypsin from GibcolBio- 
Rad Laboratories (Grand Island, NY); trypsrn and DNasel (for preparing 
cell suspensions) from Worthington (Freehold, NJ); poly+-ornithine. fetal 
bovine serum (FBS), horse and goat serum, insuline, apo-transferrin, 
putrescine, progesterone, sodium selenite, BSA, trypan blue, para- 
formaldehyde, 3,3’diaminobenzidine (DAB), and monoclonal antibody 
anti-calbindin-Dzakns from Sigma (St. Louis, MO). PH]thymidine was 
from New England Nuclear (Boston, MA). Polyclonal antibodies anti- 
calbindin and anti-synapsin I were giftsof Dr. P. C. Emson (Cambridge, 
UK) and Dr. M. B. Kennedy (Pasadena, CA). Monoclonal antibodies 
anti-MAP2 (a, b, and c forms) were a gift of Dr. S. Okabe (National 
Institutes of Health, Bethesda, MD) and Dr. N. Hirokawa (Tokyo, Ja- 
pan) or purchased from Sigma. Monoclonal antibody anti-GFAP was 
from ICN Biomedicals (Costa Mesa, CA); monoclonal and polyclonal 
anti-nestin protein were provided by Dr. M. Marvin (National Institutes 
of Health, Bethesda, MD); BrdU was from Boehringer Mannheim 
(Mannheim, Germany); monoclonal antibody against BrdU was from 
Becton Dickinson, (San Jose, CA); Vectastain ABC kit was from Vector 
laboratories (Burlingame, CA); goat antimouse IgG horseradish peroxi- 
dase conjugate was from Bio-Rad (Richmond, CA); fluorescence sec- 
ondaryantibodies were from Jackson lmmuno Research (West Grove, 
PA) and Cappel (Durham, NC); Immu-mount was from Shandon (Pitts- 
burgh, PA); DABCO was from Aldrich (Milwaukee, WI). 
Hippocampal Cell Culture 
The hippocampi from fetal brains of Sprague-Dawley rats at El6 (Ta- 
conic, Germantown, NY) were dissected free from the choroid plexus 
and meningeal tissue (Collazo et al., 1992). The hippocampi were then 
placed in ice-cold CMF-HBSS containing 0.01% DNAsel(1700-3300 
Ulmg) and chopped into small pieces. The tissue was incubated in 
the presence of 0.1% trypsin (200-300 Ulmg) and 0.4% DNAsel for 
5 min at 37%, and the trypsin activity was inhibited by addition of 10% 
FBS in DMEM. After centrifugation at 4OC, the tissue was triturated in 
CMF-HBSS containing 1% DNAsel by using a P-1000 followed by a 
P-200 Pipetman pipette. The resulting cell suspension was centrifuged 
at 4%, and the cell pellet was resuspended in CMF-HBSS. The cells 
were counted, and the viability was consistently found to be greater 
than 90% using trypan blue. 
Cells were plated onto dishes, chamber slides, or glass coverslips 
in 24 well plates coated with 15 pglml polyornithine at a density of 
45,000 cells/cm2 in DMEMIlO% FBS and incubated at 37’C under 5% 
COz. After 4 hr, the medium was replaced with a serum-free medum, 
DMEMIF12 (l:l), supplemented with 1 mM sodium pyruvate, 4 mM 
glutamine, 5 nglml insulin, 100 nglml transferrin, 100 nM putrescine, 
20 nm progesterone, 30 nM sodium selenite, 3.7 g/liter sodium bicar- 
bonate, and 100 U/ml penicillin-streptomycin (N2 medium; Botten- 
stein, 1985). In most of the experiments, bFGF was added at a concen- 
tration of 5 nglml. As a control, cells in which 100 nglml BSA instead 
of bFGF was added were grown in parallel. 
Cells were grown in bFGF until confluent. For passaging, cells were 
incubated in the presence of 0.25% trypsinl2.5 mM EDTA for 15 min 
at 37% and gently dispersed using a P-1000 Pipetman pipette. Tryp- 
sinization was inhibited by the addition of DMEM/lO% FBS, and after 
centrifugation, the cells were replated in the presence of serum- 
containing medium. This medium, 4 hr later, was replaced by N2 me- 
dium containing 5 nglml bFGF. Cells growing in N2 medium in the 
presence of bFGF were tested for ability to differentiate after passage 
2 or 3. bFGF was removed, and cells were washed and then incubated 
in N2 in the presence of 20 nglml BDNF, 20 nglml NT-3, 20 rig/ml 
NT-415, BSA, or bFGF for an additional 5 days. 
Labeling Index Determination 
Cells plated as described above were pulsed wrth BrdU at a final con- 
centration of 10 nM for 18 hr immediately prior to fixation. Then, the 
cells were fixed with 4% paraformaldehydel0.1 M  borate (Na,B,O,) 
buffer (pH 9.5) for 15 mm, treated with 2 N HCI for 10 min, and neutral- 
rzed in 0.1 M  Na2B407 for 10 min. Cells were incubated overnight with 
anti-BrdU monoclonal antibody (1:iO). Then, the cells were incubated 
with horseradish peroxidase-conjugated goat anti-mouse secondary 
antibody(l:30)for 2 hrand developed using DAB-peroxidasereaction. 
For thymidine incorporation, 2 $Xml PH]thymidine was added to 
the cultures for 18 hr. Then, the cells were washed with PBS, fixed 
with 10% tricloroacetic. and solubilized in 0.5 N NaOH. An aliquot of 
the extract was used to determine the coL,nts incorporated. 
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lmmunostaining of Cultured Cells 
lmmunocytochemistry was performed on El6 hippocampal cultures 
plated Into 4 well plastic chamber slides or glass coverslips. On differ- 
ent days of culture, cells were ftxed wtth 4% paraformaldehyde/O.l 
M  phosphate buffer (pH 7.4) for IO-15 min. After treatment with 0 1% 
Triton X-l 0015% normal goat or horse serum/PBS, the cells were incu- 
bated for 2 hr to overntght with the primary antibodies agatnst nestin 
(1 :lOOO), MAP2 (1:500; supernatant of producing cells), calbrndin-Dzsrol 
(monoclonal, 1500; polyclonal, l:lOOO), synapsin I (?:lOOO), or GFAP 
(1:50). Then, the cells were incubated with the corresponding biotinyl- 
ated secondary antibody (1:200) followed by avidin-biotin-horserad- 
rsh peroxidase complex (Vectastain ABC kit) and developed using 
DAB. For double immunocytochemistry, fluorescem- and rhodamine- 
conjugated secondary antibodies (1:lOO) at room temperature were 
used (1 hr). CoverslIps and slides were mounted tn Immu-mount or 
tn DABCOlglycerol 
Morphological Analysis of Calbindin-Expressing Cells 
The methods and equtpment used for video microscopy were the same 
as described previously (Smith, 1994). Cultures were examined on a 
Zeiss Axiovert set up for differential interference contrast optics with 
a 40 x objective. Images were collected with a Newvrcon video camera 
(Dage) processed to enhance contrast using acomputer-based system 
(Image 1; Universal Imaging). Cell body area, length of longest pro- 
cess, and number of processes and branches of the cells were mea- 
sured. 
Growth Factors, Blocking Antibodies, and Drugs 
bFGF was purchased from R & D Systems (Minneapolis, MN); BDNF 
and NT-3 were kindly provided by Dr. G. Yancopoulos (Regeneron 
Pharmaceuticals, Tarrytown, NY); NT-4/5 was purchased from Pepro- 
Tech (Rocky Hill, NJ). All growth factorswere diluted in PBS containing 
100 pglml BSA. The same solution was used as the BSA controls 
Growth factors were added to the cultures and replaced every 2-3 
days. 
Blocking antibody against NT-3 was a gift from Amgen (Thousand 
Oaks, CA). Blocking antibody against bFGF was purchased from Up- 
state Biotechnology Incorporated (Lake Placid, NY). According to the 
supplier, anti-bFGF does not cross-react with acidic FGF. They were 
added to the cultures at 1 : lOO dilution and replaced every day. 
Expression of the Results and Statistical Analysis 
To determine the number of cells, a total of 10 fields equivalent to 
500-2500 cells per sample were counted using 100 x ,200 x , or 400 x 
magnification under a phase or fluorescence microscope (Zeiss Axio- 
plan). Results are expressed as percentage of cells or as the total 
number of cells expressing a specific marker in 10 fields. For each 
condition, 4-5 samples were done, and the data are the average f 
SEM of two experiments. Morphological analysis was carried out on 
30 random cells per condition. Statistical analysis were carried out 
using Student’s t test. 
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